| pubmed-article:16717148 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16717148 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:16717148 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:16717148 | lifeskim:mentions | umls-concept:C0152171 | lld:lifeskim |
| pubmed-article:16717148 | lifeskim:mentions | umls-concept:C1332431 | lld:lifeskim |
| pubmed-article:16717148 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:16717148 | pubmed:dateCreated | 2006-5-31 | lld:pubmed |
| pubmed-article:16717148 | pubmed:abstractText | Vasoreactivity tests are fundamental in evaluating pulmonary arterial hypertension (PAH). Mutations of the transforming growth factor-beta type II receptor gene, BMPR2, predispose to the development of pulmonary hypertension and may alter the response to vasodilators. Previous investigations have not examined the relationship of BMPR2 mutations to vasoreactivity. | lld:pubmed |
| pubmed-article:16717148 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16717148 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16717148 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16717148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16717148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16717148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16717148 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16717148 | pubmed:month | May | lld:pubmed |
| pubmed-article:16717148 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:RichStuartS | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:WardKennethK | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:McGoonMichael... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:ElliottC... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:ScholandMary... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:JensenRobert... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:CarlquistJohn... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:McKinneyJason... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:KimMiryoungM | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:GlissmeyerEri... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:HavlenaGregor... | lld:pubmed |
| pubmed-article:16717148 | pubmed:author | pubmed-author:SchmidtJon... | lld:pubmed |
| pubmed-article:16717148 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16717148 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:16717148 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:16717148 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16717148 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16717148 | pubmed:pagination | 2509-15 | lld:pubmed |
| pubmed-article:16717148 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:meshHeading | pubmed-meshheading:16717148... | lld:pubmed |
| pubmed-article:16717148 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16717148 | pubmed:articleTitle | Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. | lld:pubmed |
| pubmed-article:16717148 | pubmed:affiliation | LDS Hospital, University of Utah School of Medicine, Salt Lake City, Utah, USA. ldgellio@ihc.com | lld:pubmed |
| pubmed-article:16717148 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16717148 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:659 | entrezgene:pubmed | pubmed-article:16717148 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16717148 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16717148 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16717148 | lld:pubmed |
